These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6598012)

  • 21. [In vitro cytotoxic activity of peripheral blood lymphocytes in patients with multiple sclerosis. Preliminary report].
    Czernicki J; Pacześniak J; Maciejek Z
    Neurol Neurochir Pol; 1983; 17(6):633-8. PubMed ID: 6669208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Regulation of the activity of human natural killer cells by autologous interferon].
    Cheknev SB; Ershov FI; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Sep; 118(9):281-4. PubMed ID: 7819561
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.
    Lisak RP; Zweiman B
    N Engl J Med; 1977 Oct; 297(16):850-3. PubMed ID: 904660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
    Rice GP; Casali P; Merigan TC; Oldstone MB
    Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
    Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antigamma globulin factors and IgG, IgA and IgM levels in schizophrenia, manic-depressive psychosis and disseminated sclerosis patients].
    Noeva K; Manolova Z
    Acta Microbiol Virol Immunol (Sofiia); 1976; 4():105-12. PubMed ID: 1087528
    [No Abstract]   [Full Text] [Related]  

  • 27. 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system.
    Mehling M; Kuhle J; Regeniter A
    Neurologist; 2008 Jan; 14(1):60-5. PubMed ID: 18195662
    [No Abstract]   [Full Text] [Related]  

  • 28. [Secretion of prostaglandin E by cells of human thymoma MOLT-4 and their sensitivity to cytotoxic action of NK-cells].
    Kliuchareva TE; Matveeva VA; Kushlinskiĭ NE; Uvarova EN
    Biull Eksp Biol Med; 1990 Aug; 110(8):204-6. PubMed ID: 2291974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.
    Dabholkar M; Tatake R; Amin K; Advani S; Gangal S
    Oncology; 1989; 46(2):123-7. PubMed ID: 2785254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid immune complexes in multiple sclerosis.
    Deicher H; Meyer zu Schwabedissen H; Baruth B; Patzold U; Haller P
    Experientia; 1979 Sep; 35(9):1249-50. PubMed ID: 488296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Fiblaferon-L on the human immune system.
    Zafra C; de la Fuente M; Gaytan F; Solana R; Peña J
    Chemotherapy; 1984; 30(2):131-6. PubMed ID: 6365481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosis.
    Coyle PK; Brooks BR; Hirsch RL; Cohen SR; O'Donnell P; Johnson RT; Wolinsky JS
    Lancet; 1980 Aug; 2(8188):229-32. PubMed ID: 6105395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of natural killer cell activity in mice by injection of indomethacin.
    Voth R; Chmielarczyk W; Storch E; Kirchner H
    Nat Immun Cell Growth Regul; 1986; 5(6):317-24. PubMed ID: 2432415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine analysis of cytolytic and natural killer T lymphocytes in the CSF in multiple sclerosis and other neurologic diseases.
    Weber WE; Buurman WA; Vandermeeren MM; Medaer RH; Raus JC
    Neurology; 1987 Mar; 37(3):419-25. PubMed ID: 3493450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative increase of inflammatory CD4+ T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals.
    Rotteveel FT; Kuenen B; Kokkelink I; Meager A; Lucas CJ
    Clin Exp Immunol; 1990 Jan; 79(1):15-20. PubMed ID: 1967993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methodologic characteristics of determining immunologic indices in cerebrospinal fluid].
    Totolian NA; Georgeos F; Smirnov AIu; Totolian AA
    Lab Delo; 1990; (7):57-60. PubMed ID: 1699072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural antibodies in human cerebrospinal fluid to rabbit erythrocytes.
    Fossan GO; Tönder O
    Int Arch Allergy Appl Immunol; 1975; 49(4):453-63. PubMed ID: 1171826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of 125 I myelin basic protein by serum and cerebrospinal fluid.
    Lennon V; Mackay IR
    Clin Exp Immunol; 1972 Aug; 11(4):595-603. PubMed ID: 4117459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. A simplified method for demonstrating cerebrospinal fluid oligoclonal immunoglobulin bands.
    Johnson KP; Arrigo SC; Nelson BJ; Ginsberg A
    Neurology; 1977 Mar; 27(3):273-7. PubMed ID: 557765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of clinical data in cerebrospinal fluids of patients with disseminated sclerosis with normal and increased level of gamma globulins].
    Vymazal J; Tichý J
    Cesk Neurol Neurochir; 1976 Nov; 39(6):298-304. PubMed ID: 63337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.